Imualfa 1.6mg injection 1ml is an anti-cancer drug belonging to the class of synthetic thymic peptides containing the active ingredient Thymosin Alpha 1. This medication is an adjuvant therapy in treating chronic hepatitis B and C. It is also used to treat acquired immunodeficiency syndrome(AIDS). This drug can also be used in the treatment of various types of cancer, as it can enhance the function of immune cells and promote tumor cell death. The safety of this drug during pregnancy and breastfeeding is unknown, and it is not recommended for use, so before planning for your pregnancy, please consult your doctor for more advice. This medicine may stimulate the immune system, exacerbating autoimmune diseases such as multiple sclerosis, lupus, or rheumatoid arthritis. Mainly, this drug should be used with caution in individuals with these conditions. This injection should not be used in individuals with allergies or known hypersensitivity to the medication or its components. Report to your doctor if you experience any reactions like itchy skin or rashes while taking this medicine. This drug is not recommended to individuals at increased risk of infections, such as those with a weakened immune system or those who have had recent surgery or invasive procedures, and they should be closely monitored for signs of infection while taking Imualfa 1.6mg injection 1ml. It is also important to note that this drug should not be used in immunocompromised patients or those with suppressed immunity, such as organ transplant patients, as it may increase the risk of infections.